Medicare Enrolled
Dr. Mahmood Moosa, M.D.
Endocrinology · Monroe, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Moosa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moosa?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Moosa
Dr. Mahmood Moosa is an endocrinology specialist in Monroe, MI, with 21 years of NPI registration. Based on federal Medicare data, Dr. Moosa performed 3,221 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Moosa received a total of $30,015 from 76 pharmaceutical and/or device companies across 1234 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Moosa is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 6% volume in MI
$30,015 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,221
Medicare services
Top 6% in MI for endocrinology
Not available
Unique patients (not deduplicated)
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,650 | $88 | $120 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
735 | $9 | $25 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
403 | $26 | $85 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
206 | $122 | $165 |
| New patient office visit, complex (60-74 min) | 151 | $152 | $225 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
76 | $57 | $80 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$30,015
Total received (2018-2024)
Avg $4,288/year across 7 years
Top 14% in MI for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
1,234
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,125
2023
$2,214
2022
$2,786
2021
$689
2020
$2,400
2019
$3,222
2018
$16,578
Payments by company (2024)
Dexcom, Inc.
$251
Novo Nordisk Inc
$233
Lilly USA, LLC
$195
Xeris Pharmaceuticals, Inc.
$178
Amgen Inc.
$167
Boehringer Ingelheim Pharmaceuticals, Inc.
$134
Tandem Diabetes Care, Inc.
$116
Antares Pharma, Inc.
$97
Novartis Pharmaceuticals Corporation
$96
Corcept Therapeutics
$82
Tolmar, Inc.
$69
Ascensia Diabetes Care Us Inc.
$58
Abbott Laboratories
$50
Alexion Pharmaceuticals, Inc.
$44
VIVUS LLC
$39
SANOFI-AVENTIS U.S. LLC
$35
Medtronic, Inc.
$32
BETA BIONICS, INC.
$31
RECORDATI_RARE_DISEASES_INC.
$30
Nevro Corp.
$30
Esperion Therapeutics, Inc.
$27
Kyowa Kirin, Inc.
$24
Bayer Healthcare Pharmaceuticals Inc.
$21
Mannkind Corporation
$19
Boston Scientific Corporation
$19
Amphastar Pharmaceuticals, Inc.
$18
Neurocrine Biosciences, Inc.
$16
Radius Health, Inc.
$15
Top 3 companies account for 31.9% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$15,585
Novo Nordisk Inc
$2,385
Amgen Inc.
$934
Boehringer Ingelheim Pharmaceuticals, Inc.
$875
SANOFI-AVENTIS U.S. LLC
$812
Xeris Pharmaceuticals, Inc.
$788
Dexcom, Inc.
$692
AstraZeneca Pharmaceuticals LP
$690
Amarin Pharma Inc.
$680
Corcept Therapeutics
$491
Janssen Pharmaceuticals, Inc
$434
Shire North American Group Inc
$412
Antares Pharma, Inc.
$396
Novartis Pharmaceuticals Corporation
$387
Tandem Diabetes Care, Inc.
$286
Abbott Laboratories
$260
Medtronic MiniMed, Inc.
$245
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$240
Merck Sharp & Dohme Corporation
$226
Becton, Dickinson and Company
$198
RECORDATI_RARE_DISEASES_INC.
$160
Regeneron Healthcare Solutions, Inc.
$122
Amneal Pharmaceuticals LLC
$115
Acella Pharmaceuticals, LLC
$108
Radius Health, Inc.
$107
Nevro Corp.
$104
AbbVie, Inc.
$100
Insulet Corporation
$97
LIFESCAN, INC.
$94
AbbVie Inc.
$90
MannKind Corporation
$89
Medtronic, Inc.
$89
Supernus Pharmaceuticals, Inc.
$88
ABBVIE INC.
$87
Bayer HealthCare Pharmaceuticals Inc.
$84
Alexion Pharmaceuticals, Inc.
$82
Ascensia Diabetes Care Us Inc.
$80
VIVUS LLC
$77
Esperion Therapeutics, Inc.
$76
Zealand Pharma US, Inc.
$70
Tolmar, Inc.
$69
IBSA Pharma Inc.
$58
Ascendis Pharma Inc
$56
Ultragenyx Pharmaceutical Inc.
$55
PFIZER INC.
$51
Horizon Therapeutics plc
$50
Merck Sharp & Dohme LLC
$50
VIVUS, Inc.
$49
Vifor Pharma, Inc.
$44
DEXCOM, INC.
$39
Embecta Corp.
$35
CeQur Corporation
$35
BETA BIONICS, INC.
$31
Mannkind Corporation
$31
GRT US Holding, Inc.
$28
Checkpoint Surgical, Inc
$27
Strongbridge US INC.
$27
Eisai Inc.
$26
Kyowa Kirin, Inc.
$24
Currax Pharmaceuticals LLC
$23
Valeritas, Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$21
Senseonics, Incorporated
$19
Astellas Pharma US Inc
$19
Boston Scientific Corporation
$19
Acerus Pharmaceuticals Corporation
$18
Amphastar Pharmaceuticals, Inc.
$18
EUSA Pharma (US) LLC
$17
Orexigen Therapeutics, Inc.
$17
Ipsen Biopharmaceuticals, Inc
$17
Neurocrine Biosciences, Inc.
$16
OPKO Pharmaceuticals, LLC
$15
Roche Diabetes Care, Inc.
$14
EISAI INC.
$14
ARBOR PHARMACEUTICALS, INC.
$13
Alvogen Inc
$12
Top 3 companies account for 63.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · Belviq · CHANTIX · CONTRAVE · CYCLOSET · CeQur Simplicity · Checkpoint Stimulators · Corlanor · Crysvita · Cryvista · DC ACCU-CHEK FASTCLIX Lancet and Device Kit · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · Eversense · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Lite system · GATTEX · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · HUMULIN R 500 · HYPERLIPIDEMIA - DISEASE · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LYRICA · MACRILEN · MINIMED 780G · MOUNJARO · Macrilen · Minimed 530G · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid · Natesto · Norditropin · ONETOUCH VERIO FLEX · ONETOUCH VERIO REFLECT · OTREXUP · Omnipod · Otrexup · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREMARIN · Prolia · QSYMIA · Qutenza · RAYOS · RECORLEV · Rayaldee · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Senza · Strensiq · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Triptodur · Tymlos · UNITHROID · V-GO · Vascepa · Veozah · Victoza · XARELTO · XIFAXAN · XYOSTED · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
26
County median income
$75,272
Nearest hospital to ZIP centroid (approximate)
PROMEDICA MONROE REGIONAL HOSPITAL
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Moosa is a clinical cardiology specialist, with above-average Medicare volume (top 6% in MI), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Moosa experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Moosa performed 1,650 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Moosa receive payments from pharmaceutical companies?
Yes. Dr. Moosa received a total of $30,015 from 76 companies across 1,234 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Moosa's costs compare to other endocrinologists in Monroe?
Dr. Moosa's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Moosa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Monroe
Browse endocrinologists in Monroe ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in MI
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in MI
Which MI endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology